Development and Translation of Medical Technologies that Reduce Health Disparities (SBIR [R43/R44]) |
The summary for the Development and Translation of Medical Technologies that Reduce Health Disparities (SBIR [R43/R44]) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.
-
Federal Grant Title: Development and Translation of Medical Technologies that Reduce Health Disparities (SBIR [R43/R44]) CFDA Number: 93.242 CFDA Description: Mental Health Research Grants Federal Agency Name: National Institutes of Health Category of Funding Activity: Health Category Explanation: Information not provided Opportunity Category: Discretionary Funding Opportunity Number: RFA-EB-10-002 Document Type: Grants Notice Funding Instrument Type: Grant Posted Date: Mar 19, 2010 Creation Date: Mar 19, 2010 Original Closing Date for Applications: Jan 07, 2011 Current Closing Date for Applications: Jan 07, 2011 Archive Date: Feb 07, 2011 Expected Number of Awards: Information not provided Estimated Total Program Funding: $3,450,000 Federal Grant Award Ceiling: Information not provided Federal Grant Award Floor: Information not provided Cost Sharing or Matching Requirement: No
- Applicants Eligible for this Grant
- Small businesses
- Additional Information on Eligibility
- Information not provided
- Grant Description
- Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop and translate medical technologies aimed at reducing disparities in healthcare access and health outcomes. Appropriate medical technologies should be effective, affordable, culturally acceptable, and deliverable to those who need them. Responsive grant applications must involve a formal collaboration with a healthcare provider or other healthcare organization serving a health disparity population. Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications. Funds Available and Anticipated Number of Awards. The estimated amount of funds available for support of 7-12 projects awarded as a result of this announcement is $3.45 million for fiscal year 2011. Future year amounts will depend on annual appropriations.
- Link to Full Grant Announcement
-
http://grants.nih.gov/grants/guide/rfa-files/rfa-eb-10-002.html
- Grant Announcement Contact
- NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV] - Similar Government Grants
- • Discovery, Development, and Testing of Novel Interventions to Advance HIV Prevention and Care (R21)
- • Discovery, Development, and Testing of Novel Interventions to Advance HIV Prevention and Care (R03)
- • Advancing the Impact of Effective HIV/AIDS Prevention and Treatment Interventions (R03)
- • Discovery, Development, and Testing of Novel Interventions to Advance HIV Prevention and Care (R34)
- • Advancing the Impact of Effective HIV/AIDS Prevention and Treatment Interventions (R34)
- • Development of Biomarkers for Mental Health Research and Clinical Utilities: (STTR [R41/R42])
- • Development of Biomarkers for Mental Health Research and Clinical Utilities (SBIR [R43/R44])
- • Pharmacologic Agents and Drugs for Mental Disorders (SBIR [R43/R44])
- • Pharmacologic Agents and Drugs for Mental Disorders (STTR [R41/R42])
- • Solicitation of Assays for High Throughput Screening (HTS) in the Molecular Libraries Screening Cent...
